145 related articles for article (PubMed ID: 32758941)
21. Characteristics of patients with chronic idiopathic interstitial pneumonia undergoing repeated respiratory-related hospitalizations: A retrospective cohort study.
Yamazaki R; Nishiyama O; Saeki S; Sano H; Iwanaga T; Tohda Y
PLoS One; 2020; 15(4):e0232212. PubMed ID: 32330195
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of the Diagnostic Efficacies of Serological Markers KL-6, SP-A, SP-D, CCL2, and CXCL13 in Idiopathic Interstitial Pneumonia.
Xue M; Guo Z; Cai C; Sun B; Wang H
Respiration; 2019; 98(6):534-545. PubMed ID: 31665737
[TBL] [Abstract][Full Text] [Related]
23. STAT-3 contributes to pulmonary fibrosis through epithelial injury and fibroblast-myofibroblast differentiation.
Pedroza M; Le TT; Lewis K; Karmouty-Quintana H; To S; George AT; Blackburn MR; Tweardy DJ; Agarwal SK
FASEB J; 2016 Jan; 30(1):129-40. PubMed ID: 26324850
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-13 and its receptors in idiopathic interstitial pneumonia: clinical implications for lung function.
Park SW; Ahn MH; Jang HK; Jang AS; Kim DJ; Koh ES; Park JS; Uh ST; Kim YH; Park JS; Paik SH; Shin HK; Youm W; Park CS
J Korean Med Sci; 2009 Aug; 24(4):614-20. PubMed ID: 19654941
[TBL] [Abstract][Full Text] [Related]
25. Comparative proteome analysis of lung tissue from patients with idiopathic pulmonary fibrosis (IPF), non-specific interstitial pneumonia (NSIP) and organ donors.
Korfei M; von der Beck D; Henneke I; Markart P; Ruppert C; Mahavadi P; Ghanim B; Klepetko W; Fink L; Meiners S; Krämer OH; Seeger W; Vancheri C; Guenther A
J Proteomics; 2013 Jun; 85():109-28. PubMed ID: 23659799
[TBL] [Abstract][Full Text] [Related]
26. Characterization of air flow and lung function in the pulmonary acinus by fluid-structure interaction in idiopathic interstitial pneumonias.
Chen L; Zhao X
PLoS One; 2019; 14(3):e0214441. PubMed ID: 30921412
[TBL] [Abstract][Full Text] [Related]
27. Serum decorin is a potential prognostic biomarker in patients with acute exacerbation of idiopathic pulmonary fibrosis.
Nikaido T; Tanino Y; Wang X; Sato Y; Togawa R; Kikuchi M; Misa K; Saito K; Fukuhara N; Kawamata T; Rikimaru M; Umeda T; Morimoto J; Koizumi T; Suzuki Y; Hirai K; Uematsu M; Minemura H; Fukuhara A; Sato S; Saito J; Yokouchi H; Kanazawa K; Shibata Y
J Thorac Dis; 2018 Sep; 10(9):5346-5358. PubMed ID: 30416782
[TBL] [Abstract][Full Text] [Related]
28. TRIM33 prevents pulmonary fibrosis by impairing TGF-β1 signalling.
Boutanquoi PM; Burgy O; Beltramo G; Bellaye PS; Dondaine L; Marcion G; Pommerolle L; Vadel A; Spanjaard M; Demidov O; Mailleux A; Crestani B; Kolb M; Garrido C; Goirand F; Bonniaud P
Eur Respir J; 2020 Jun; 55(6):. PubMed ID: 32184320
[TBL] [Abstract][Full Text] [Related]
29. Protective role of cytochrome P450 1A1 (CYP1A1) against benzo[a]pyrene-induced toxicity in mouse aorta.
Uno S; Sakurai K; Nebert DW; Makishima M
Toxicology; 2014 Feb; 316():34-42. PubMed ID: 24394547
[TBL] [Abstract][Full Text] [Related]
30. Reduced expression of BMP3 contributes to the development of pulmonary fibrosis and predicts the unfavorable prognosis in IIP patients.
Yu X; Gu P; Huang Z; Fang X; Jiang Y; Luo Q; Li X; Zhu X; Zhan M; Wang J; Fan L; Chen R; Yu J; Gu Y; Liang A; Yi X
Oncotarget; 2017 Oct; 8(46):80531-80544. PubMed ID: 29113323
[TBL] [Abstract][Full Text] [Related]
31. Vitamin D deficiency exacerbates bleomycin-induced pulmonary fibrosis partially through aggravating TGF-β/Smad2/3-mediated epithelial-mesenchymal transition.
Li SR; Tan ZX; Chen YH; Hu B; Zhang C; Wang H; Zhao H; Xu DX
Respir Res; 2019 Nov; 20(1):266. PubMed ID: 31775746
[TBL] [Abstract][Full Text] [Related]
32. Osteopontin silencing attenuates bleomycin-induced murine pulmonary fibrosis by regulating epithelial-mesenchymal transition.
Hatipoglu OF; Uctepe E; Opoku G; Wake H; Ikemura K; Ohtsuki T; Inagaki J; Gunduz M; Gunduz E; Watanabe S; Nishinaka T; Takahashi H; Hirohata S
Biomed Pharmacother; 2021 Jul; 139():111633. PubMed ID: 34243624
[TBL] [Abstract][Full Text] [Related]
33. Transmembrane protease, serine 4 (TMPRSS4) is upregulated in IPF lungs and increases the fibrotic response in bleomycin-induced lung injury.
Valero-Jiménez A; Zúñiga J; Cisneros J; Becerril C; Salgado A; Checa M; Buendía-Roldán I; Mendoza-Milla C; Gaxiola M; Pardo A; Selman M
PLoS One; 2018; 13(3):e0192963. PubMed ID: 29529050
[TBL] [Abstract][Full Text] [Related]
34. Plasminogen activator inhibitor-1 suppresses profibrotic responses in fibroblasts from fibrotic lungs.
Marudamuthu AS; Shetty SK; Bhandary YP; Karandashova S; Thompson M; Sathish V; Florova G; Hogan TB; Pabelick CM; Prakash YS; Tsukasaki Y; Fu J; Ikebe M; Idell S; Shetty S
J Biol Chem; 2015 Apr; 290(15):9428-41. PubMed ID: 25648892
[TBL] [Abstract][Full Text] [Related]
35. Bleomycin Induces Drug Efflux in Lungs. A Pitfall for Pharmacological Studies of Pulmonary Fibrosis.
Park JK; Coffey NJ; Bodine SP; Zawatsky CN; Jay L; Gahl WA; Kunos G; Gochuico BR; Malicdan MCV; Cinar R
Am J Respir Cell Mol Biol; 2020 Feb; 62(2):178-190. PubMed ID: 31419911
[TBL] [Abstract][Full Text] [Related]
36. Loss of PTEN induces lung fibrosis via alveolar epithelial cell senescence depending on NF-κB activation.
Tian Y; Li H; Qiu T; Dai J; Zhang Y; Chen J; Cai H
Aging Cell; 2019 Feb; 18(1):e12858. PubMed ID: 30548445
[TBL] [Abstract][Full Text] [Related]
37. IL-17A contributes to HSV1 infection-induced acute lung injury in a mouse model of pulmonary fibrosis.
Chen T; Qiu H; Zhao MM; Chen SS; Wu Q; Zhou NY; Lu LQ; Song JC; Tang DL; Weng D; Li HP
J Cell Mol Med; 2019 Feb; 23(2):908-919. PubMed ID: 30378252
[TBL] [Abstract][Full Text] [Related]
38. Upregulation of RGS2: a new mechanism for pirfenidone amelioration of pulmonary fibrosis.
Xie Y; Jiang H; Zhang Q; Mehrotra S; Abel PW; Toews ML; Wolff DW; Rennard S; Panettieri RA; Casale TB; Tu Y
Respir Res; 2016 Aug; 17(1):103. PubMed ID: 27549302
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical study of fibrosis and adenocarcinoma in dominant-negative p53 transgenic mice exposed to chrysotile asbestos and benzo(a)pyrene.
Yee H; Yie TA; Goldberg J; Wong KM; Rom WN
J Environ Pathol Toxicol Oncol; 2008; 27(4):267-76. PubMed ID: 19105532
[TBL] [Abstract][Full Text] [Related]
40. Aortic carboxypeptidase-like protein (ACLP) enhances lung myofibroblast differentiation through transforming growth factor β receptor-dependent and -independent pathways.
Tumelty KE; Smith BD; Nugent MA; Layne MD
J Biol Chem; 2014 Jan; 289(5):2526-36. PubMed ID: 24344132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
